Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R E Moore

Showing results (131-140 of 173) with videos related to

Pageof 18
Sort By:
Journal of Pediatric Gastroenterology and Nutrition|January 1, 1989
Longitudinal assessment of type I procollagen in children with inflammatory bowel disease subjected to surgeryJ S Hyams, R E Moore, A M Leichtner, et al.
Progress in Clinical and Biological Research|January 1, 1983
Room temperature-stable biocompatible fluorocarbon emulsionsL C Clark, E W Clark, R E Moore, et al.
Planta Medica|April 1, 1993
Inhibition of reverse transcriptase activity by extracts of cultured blue-green algae (cyanophyta)A F Lau, J Siedlecki, J Anleitner, et al.
Psychiatry Research|May 16, 2000
Seasonal variations in internalizing, externalizing, and substance use disorders in youthP A Kovalenko, C W Hoven, J Wicks, et al.
Journal of Natural Products|November 1, 1990
Lyngbyatoxins B and C, two new irritants from Lyngbya majusculaN Aimi, H Odaka, S Sakai, et al.
Molecular Pharmacology|October 1, 1991
Cyanobacterial nodularin is a potent inhibitor of type 1 and type 2A protein phosphatasesR E Honkanen, M Dukelow, J Zwiller, et al.
Journal of Natural Products|April 28, 1999
Symplostatin 2: a dolastatin 13 analogue from the marine cyanobacterium Symploca hydnoidesG G Harrigan, H Luesch, W Y Yoshida, et al.
Japanese Journal of Cancer Research : Gann|April 1, 1985
A blue-green alga from Okinawa contains aplysiatoxins, the third class of tumor promotersH Fujiki, K Ikegami, H Hakii, et al.
American Journal of Public Health|December 1, 1993
Nemesis revisited: tuberculosis infection in a New York City men's shelterE A Paul, S M Lebowitz, R E Moore, et al.
Cancer Research|April 1, 1983
Comparative effects of aplysiatoxin, debromoaplysiatoxin, and teleocidin on receptor binding and phospholipid metabolismA D Horowitz, H Fujiki, I B Weinstein, et al.
Pageof 18

Showing results (131-140 of 173) with videos related to

Sort By:
Pageof 18
Journal of Pediatric Gastroenterology and Nutrition|January 1, 1989
Longitudinal assessment of type I procollagen in children with inflammatory bowel disease subjected to surgeryJ S Hyams, R E Moore, A M Leichtner, et al.
Progress in Clinical and Biological Research|January 1, 1983
Room temperature-stable biocompatible fluorocarbon emulsionsL C Clark, E W Clark, R E Moore, et al.
Planta Medica|April 1, 1993
Inhibition of reverse transcriptase activity by extracts of cultured blue-green algae (cyanophyta)A F Lau, J Siedlecki, J Anleitner, et al.
Psychiatry Research|May 16, 2000
Seasonal variations in internalizing, externalizing, and substance use disorders in youthP A Kovalenko, C W Hoven, J Wicks, et al.
Journal of Natural Products|November 1, 1990
Lyngbyatoxins B and C, two new irritants from Lyngbya majusculaN Aimi, H Odaka, S Sakai, et al.
Molecular Pharmacology|October 1, 1991
Cyanobacterial nodularin is a potent inhibitor of type 1 and type 2A protein phosphatasesR E Honkanen, M Dukelow, J Zwiller, et al.
Journal of Natural Products|April 28, 1999
Symplostatin 2: a dolastatin 13 analogue from the marine cyanobacterium Symploca hydnoidesG G Harrigan, H Luesch, W Y Yoshida, et al.
Japanese Journal of Cancer Research : Gann|April 1, 1985
A blue-green alga from Okinawa contains aplysiatoxins, the third class of tumor promotersH Fujiki, K Ikegami, H Hakii, et al.
American Journal of Public Health|December 1, 1993
Nemesis revisited: tuberculosis infection in a New York City men's shelterE A Paul, S M Lebowitz, R E Moore, et al.
Cancer Research|April 1, 1983
Comparative effects of aplysiatoxin, debromoaplysiatoxin, and teleocidin on receptor binding and phospholipid metabolismA D Horowitz, H Fujiki, I B Weinstein, et al.
Pageof 18